Immunotherapy Is Evolving and Promising for Lung Cancer

Article Information

DOI 
http://dx.doi.org/10.1177/1559897715588457
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2015 SAGE Publications

Author Information

  1. Kathy Boltz, PhD
  1. Solange Peters, MD, PhD
    1. Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
  2. Martin Reck, MD, PhD
    1. Lung Clinic Grosshansdorf, Grosshansdorf, Germany
  3. Johan Vansteenkiste, MD, PhD
    1. University Hospital KU Leuven, Leuven Lung Cancer Group, Leuven, Belgium
  4. David P. Carbone, MD, PhD
    1. Ohio State University, Columbus, Ohio, USA
View Full Text

Article usage

AbstractFullPDF
May 20151331
Jun 20151431
Jul 2015900
Aug 20157100
Sep 201513911
Oct 20151533
Nov 201529721
Total558127

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Immunotherapy Is Evolving and Promising for Lung Cancer
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

nivolumab
MAGRIT
lung neoplasms/therapy
cancer vaccines
ipilimumab
pembrolizumab
MPLD3280A
MEDI4736
PD-1 inhibition
PD-L1 inhibition
immune checkpoint modulator
immunotherapies
clinical trial design